-
Fucoxanthin CAS:3351-86-8 Mea Hana Mea Hoʻolako
ʻO Fucoxanthin kekahi xanthophyll koʻikoʻi. Loaʻa nui ia i nā heterokontophyta, e like me ka algae ʻeleʻele a me ka microalgae moana, a ua manaʻo ʻia ʻo ia ka lua o ka carotenoid nui loa ma ka Honua ma hope o ka β-carotene. I kēia mau lā iho nei, ua hana nui ʻia nā haʻawina e pili ana i ka hana o ka fucoxanthin, a ua hōʻike ʻia ka fucoxanthin he mau hana physiological maikaʻi like ʻole.
-
ʻO Sitagliptin Phosphate CAS:654671-78-0 Mea Hana Mea Hoʻolako
ʻO ka Sitagliptin Phosphateʻo ia ka mea hoʻopaʻa dipeptidyl peptidase IV mua loa mai Merck no ka mālama ʻana i ka maʻi diabetes type 2 me ka ʻole o ka piʻi ʻana o ke kaumaha a ua like ka nui o ka hypoglycemia me ka placebo. Hana ʻo Sitagliptin ma ka hoʻoikaika ʻana i ka ʻōnaehana incretin o ke kino, kahi e kōkua ai i ka hoʻoponopono ʻana i ka glucose ma o ka hoʻopilikia ʻana i nā cell β a me α i loko o ka pancreas.
-
ʻAsparagine Mono CAS:5794-13-8 Mea Hana Mea Hoʻolako
ʻAsparagine MonoHoʻoulu ʻia e ka glutamine-dependent asparagine synthetase i loko o nā ʻiʻo mammalian. Loaʻa i ka Asparagine ka ratio nitrogen kiʻekiʻe i ke kalapona a he mea hoʻoponopono koʻikoʻi no ka mālama ʻana a me ka lawe ʻana i ka nitrogen. ʻO kona hoʻohaʻahaʻa wela i ke alo o nā kō e alakaʻi ai i ka hoʻokumu ʻana o ka acrylamide i nā meaʻai.ʻAsparagine Monolawelawe ʻo ia ma ke ʻano he kumu hoʻololi waikawa amino a he mea nui ia no ka homeostasis waikawa amino. Kākoʻo ia i ka ulu ʻana o nā cell cancer.
-
L-Carnitine Hydrochloride CAS:10017-44-4 Mea Hana Mea Hoʻolako
ʻO L-Carnitine hydrochloride ((R)-Carnitine hydrochloride), kahi zwitterion liʻiliʻi a polar loa, he kumu hui koʻikoʻi no ke ala β-oxidation mitochondrial. Hana ʻo L-Carnitine hydrochloride i ka lawe ʻana i nā acyl-CoAs momona kaulahao lōʻihi i loko o ka mitochondria no ka hoʻohaʻahaʻa ʻia e ka β-oxidation.
-
ʻO Dipyridamol CAS:58-32-2 Mea Hana Mea Hoʻolako
He vasodilator hana lōʻihi ʻo Dipyridamol. He koho kona hana vasodilating no ka ʻōnaehana coronary; ua hōʻike ʻia no ka lāʻau lapaʻau lōʻihi o ka angina pectoris mau loa. Hoʻopaʻa pū ka lāʻau i ka adenosine deaminase i loko o nā erythrocytes a hoʻopilikia i ka lawe ʻana o ka adenosine vasodilator e nā erythrocytes. Hoʻoikaika kēia mau hana i ka hopena o ka prostacyclin (PGI2), ka mea e hana ana ma ke ʻano he mea hoʻopaʻa i ka platelet aggregation.
-
ʻO Losartan Potassium CAS:124750-99-8 Mea Hana Mea Hoʻolako
ʻO Losartan Potassium ka paʻakai potassium o losartan me ka hana antihypertensive, kahi i hoʻohana nui ʻia i ka mālama ʻana i ke koko kiʻekiʻe (hypertension) a me ka diabetic nephropathy. Hana ia ma ka hoʻomaha ʻana i nā kīʻaha koko i hiki ai i ke koko ke kahe maʻalahi. He mea pono nō hoʻi ia e kōkua i ka pale ʻana i nā puʻupaʻa mai ka hōʻino ʻia e ka maʻi diabetes a hoʻohaʻahaʻa i nā pilikia o ka hahau ʻana i nā poʻe maʻi e loaʻa ana i ka hypertension a me ka hoʻonui ʻana o ka myocardial.
-
TUDCA CAS:14605-22-2 Mea Hana Mea Hoʻolako
ʻO ka waikawa Tauroursodeoxycholic (TUDCA) kahi waikawa bile hydrophilic i hana ʻia i loko o nā hepatocytes ma o ka hui ʻana o ka waikawa ursodeoxycholic (UDCA) me ka waikawa amino taurine. ʻO UDCA, i hana ʻia e nā bacteria ʻōpū, ua ʻāpono ʻia e ka FDA ma ʻAmelika Hui Pū ʻIa no ka mālama ʻana i kekahi mau maʻi ate cholestatic. Hana nā kānaka i ka TUDCA i kekahi ʻano, akā loaʻa ia i nā nui he nui i loko o ka bile o nā bea. ʻO ka TUDCA kahi mea pale maʻamau o ke kaumaha endoplasmic reticulum (ER).
-
Carnitine HCL CAS:6645-46-1 Mea Hana Mea Hoʻolako
Carnitine HCLhe waikawa amino nona ke kuleana e pāʻani i ke kaʻina hana metabolism momona o ke kino. Hoʻoili ʻo L-Carnitine i nā waikawa momona i ka mitochondria, kahi e puhi ʻia ai lākou ma ke ʻano he wahie. Loaʻa maoli kēia waikawa amino, ʻoiai hiki ke biosynthesized ʻia mai ʻelua mau mea ʻē aʻe. Ma waho aʻe o ka loaʻa ʻana i nā ʻano meaʻai like ʻole, loaʻa pinepine ʻia hoʻi ia ma ke ʻano he mea hoʻohui meaʻai.
-
DL-Alpha-Ketoisoleucine Calcium CAS:66872-75-1
DL-ʻAlepa-Ketoisoleucine Calcium ua hoʻohana nui ʻia e pale a mālama i nā maʻi metabolism protein i hoʻokumu ʻia e ka maʻi renal insufficiency.These huahana hiki ke hoʻopili nui ʻia i ka lāʻau lapaʻau, reagent, ʻoihana kemika maikaʻi, a me ka mea hoʻohui o nā kahua meaʻai etc.
-
ʻO Citalopram Hydrobromide CAS: 59729-32-7
ʻO Citalopram hydrobromide (citalopram HBr) kahi mea hoʻopaʻa serotonin reuptake koho (SSRI) i hāʻawi waha ʻia me kahi ʻano kemika i pili ʻole i nā SSRI ʻē aʻe a i ʻole tricyclic, tetracyclic, a i ʻole nā mea antidepressant ʻē aʻe i loaʻa. Loaʻa ʻo Citalopram HBr ma ke ʻano he pauka maikaʻi, keʻokeʻo a keʻokeʻo paha. He mea hoʻoheheʻe iki ʻo Citalopram HBr i ka wai a hoʻoheheʻe ʻia i ka ethanol.
-
Piracetam CAS:7491-74-9 Mea Hoʻolako Mea Hana
He hui organonitrogen a he hui organooxygen ka Piracetam. Pili ia i ka hana me ka waikawa alpha-amino. He hui ia i manaʻo ʻia he nootropic a he mea pale neuroprotective. He mea nootropic ka Piracetam me kahi hōʻailona ma ke ʻano he lāʻau lapaʻau adjunctive no ka myoclonus o ke kumu cortical, a me ka tardive dyskinesia.
-
ʻO Solifenacin Succinate CAS:242478-38-2 Mea Hana Mea Hoʻolako
ʻO Solifenacin succinate kahi lāʻau antimuscarinic i hoʻohana ʻia e mālama i kahi ʻōpū mimi overactive e hoʻoulu ai i nā hōʻailona o ka pinepine, ka wikiwiki, a i ʻole ka incontinence. ʻO Solifenacin kahi antagonist receptor muscarinic M3 i hoʻomohala ʻia a hoʻokuʻu ʻia no ka mālama ʻana i ka ʻōpū mimi overactive (pollakiuria) ma ʻEulopa. Ua pili nā mea loaʻa M3 i nā ʻūlū ʻiʻo laumania i hoʻoulu ʻia e ka neurally, a ua kānalua ʻia hoʻi nā mea loaʻa M2 e pāʻani ana i kahi kuleana ma muli o ko lākou mana ma ka ʻiʻo detrusor.
